AMOXIL Drug Patent Profile

Which patents cover Amoxil, and what generic alternatives are available?

Amoxil is a drug marketed by Glaxosmithkline and Us Antibiotics and is included in eight NDAs.

The generic ingredient in AMOXIL is amoxicillin. There are forty-six drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Amoxil

A generic version of AMOXIL was approved as amoxicillin by TEVA on December 22^nd, 1992.

Summary for AMOXIL

US Patents:	0
Applicants:	2
NDAs:	8
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	69
Clinical Trials:	20
Patent Applications:	3,059
DailyMed Link:	AMOXIL at DailyMed

Recent Clinical Trials for AMOXIL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Dow University of Health Sciences	Phase 4
Boston Children's Hospital	Phase 4
Boston Children’s Hospital	Phase 4

See all AMOXIL clinical trials

Pharmacology for AMOXIL

Drug Class

Penicillin-class Antibacterial

US Patents and Regulatory Information for AMOXIL

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Glaxosmithkline	AMOXIL	amoxicillin	CAPSULE;ORAL	050459-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No
Us Antibiotics	AMOXIL	amoxicillin	TABLET;ORAL	050754-001	Jul 10, 1998		DISCN	Yes	No
Glaxosmithkline	AMOXIL	amoxicillin	FOR SUSPENSION;ORAL	050460-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No
Us Antibiotics	AMOXIL	amoxicillin	CAPSULE;ORAL	062216-004	Approved Prior to Jan 1, 1982	AB	RX	No	No
Us Antibiotics	AMOXIL	amoxicillin	FOR SUSPENSION;ORAL	050760-002	Apr 15, 1999	AB	RX	Yes	No
Us Antibiotics	AMOXIL	amoxicillin	FOR SUSPENSION;ORAL	062226-005	Approved Prior to Jan 1, 1982	AB	RX	No	No
Us Antibiotics	AMOXIL	amoxicillin	TABLET, CHEWABLE;ORAL	050761-002	Apr 15, 1999		DISCN	No	No